Organizations are currently faced with a choice between creating a surplus and delaying clinical trials, but an integrated just-in-time IRT solution may be the answer to simplifying the clinical supply chain.
Most Recent Flipbooks
Boosting Trial Success through Blinded Data Analytics: What Can We Learn from CNS
Psychiatry studies, based on the clinician's assessment of disease progression or severity, have modest success rates. But is it true that so many medications don’t work, or is something else at play?
The Difference a Step Makes - International Clinical Trials
Signant Health explains why a purpose-built clinical supply chain platform is a must-have for 2020 and beyond.
Measuring Subjective Outcomes Objectively: How Technology Can Boost Data Quality and Endpoint Reliability
Dr Todd Everhart speaks to the Journal of mHealth about the need to improve endpoint quality, and how technology holds the key to collecting meaningful, quality data.
Building Patient Engagement and Secure Drug Discovery - Data Privacy, Compliance, and Security
Much has been made of the trials and tribulations of complying with data regulations; however, Paul Drake from Signant argues there may be significant opportunities to be gained from data compliance
Delving into eConsent: Industry Survey Reinforces Patient Centricity
Signant conducted an electronic informed consent (eConsent) survey to obtain insights from sponsors and CROs. Here are the findings from this key piece of research
PharmaVoice - Leveraging Virtual Technology to Improve Processes
In this issue of PharmaVoice, Signant Health's Bill Byrom shares his viewpoint of the potential of virtual health.
Wear it on Your Sleeve — How Sensors and Wearables Help Drive Richer Insights on Intervention Effects
As previously featured in PharmaVoice, Bill Byrom shares how the use of sensors and wearables in clinical trials can help replace the subjectivity of eCOA data collected with objective, accurate data.
The Changing Face of Oncology Endpoint Monitoring
Oncology trials have always relied on tumor response to gauge efficacy. But in a world of patient-centricity and value-based reimbursement, do these "hard endpoints” the whole story?
Successful Oncology Trials Need Intelligent Supply Management
eConsent Tearing Down Barriers to Oncology Trials
Journal for Clinical Studies Article: eConsent: Tearing Down Barriers to Oncology Trials, co-authored by Neetu Pundir & Bill Byrom, Signant Health.
Power of Mobile Technology to Optimize Patient Engagement
Power of Mobile Technology to Optimize Patient Engagement and Study Success, article, authored by Neetu Pundir, Signant Health, published in the Journal for Clinical Studies.
ePRO for the Modern Trial: Considerations to Implementing a BYOD or Partial Provisioning Strategy
Improving Outcomes in Diabetes Research
Leveraging Technology to Develop New Trial Endpoints
eConsent Regulatory Myths_PME_NPundir
Optimizing Outcomes - Reduce the Burden of Data Collection - Oncology
An IRB Perspective on Improving Informed Consent
What the Future Holds for Informed Consent
Recruitment & Retention: Breaking Down the Barriers to eConsent Adoption